Page 1

DEFINITIVE HEALTHCARE Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2021 November 8 , 2021 Third quarter revenue grew 43 % year - over - year to $ 43.1 million FRAMINGHAM , Mass . , Nov. 08 , 2021 ( GLOBE NEWSWIRE ) -- Definitive Healthcare Corp. ( " Definitive Healthcare " ) ( Nasdaq : DH ) , an industry leader in healthcare commercial intelligence , today announced financial results for the quarter ended September 30 , 2021 . Third Quarter 2021 Financial and Other Recent Highlights : Financial Highlights : • Revenue was $ 43.1 million , an increase of 43 % from $ 30.1 million in Q3 2020 . • GAAP Net loss was $ ( 21.0 ) million , or 49 % of revenue , compared to $ 10.0 million , or 33 % of revenue in Q3 2020 . • Adjusted Net Income was $ 2.2 million , compared to $ 5.1 million in Q3 2020 . • Adjusted EBITDA was $ 14.4 million , or 33 % of revenue , compared to $ 14.5 million , or 48 % of revenue in Q3 2020 . • Cash flow from operations was ( $ 0.9 ) million in the quarter or -2 % of revenue . For the trailing twelve - month period , cash flow from operations was $ 29.7 million , or 19 % of revenue . • Unlevered free cash flow was $ 11.5 million in the quarter , or 27 % of revenue . For the trailing twelve - month period , unlevered free cash flow was $ 59.1 million , or 38 % of revenue . " I am extremely pleased with our performance in our first quarter as a public company , " said Jason Krantz , founder and CEO of Definitive Healthcare . " We saw strong revenue growth and continued to produce exceptional results . Our strength was broad - based across all of our segments , and we continue to innovate to build the next generation of healthcare commercial intelligence solutions . I want to thank all of our employees who have worked so diligently to help our customers create new paths to commercial success in the healthcare market . " Recent Business and Operating Highlights : • Definitive Healthcare successfully completed its initial public offering in September after selling 17,888,888 shares at a price of $ 27.00 per share , for aggregate gross proceeds of approximately $ 483 million . • The company ended the quarter with 377 customers with $ 100,000 or greater in annual recurring revenue , a 49 % increase from 252 in Q3 2020 . . During the third quarter , the company brought on multiple new customers including : o A large pharmaceutical technology company , who plans to use Definitive Healthcare commercial intelligence on executives , affiliations , procedure volumes , and doctors to accelerate its push into the hospital and IDN market for a new drug delivery implantable device . o A market leader in the EHR market , who plans to use the Definitive Healthcare platform to identify which practices are using its competition's software , understand usage data including hospital bed counts and clinical metrics , and gain insight into the nature of the practices ' patients using claims data . o One of the world's leading venture capital firms , who will use Definitive Healthcare commercial intelligence to help them size and evaluate the market for potential investments in the healthcare space . o One of the world's largest global logistics providers , who subscribed to the Definitive Healthcare platform to help validate location and address data to ensure accurate package delivery to physicians and other healthcare providers . • The company continues to deliver product innovations in response to customer demand . Some of these recent innovations include : o An expansion of the Physician View product to include new intelligence around physician specialties , which allows